Clinical Trials Logo

Clinical Trial Summary

Research Title PATTERN OF CLINICAL PRESENTATION OF DIFFERENT BREAST DISEASE IN SURGICAL OPD AT BPKIHS Rationale: The Study will help us to know about pattern of presentation of different breast diseases Aims and Objectives: 1. To investigate the pattern of symptoms in patients with Breast diseases 2. To assess the burden of different Breast diseases. Research Hypothesis (if relevant): N/A 1. Material & Methods: 1. Whether study involves Human/animals or both : Human 2. Population/ participants: Files of patients presenting in Surgical OPD with Breast related complaints 3. Type of study design: : Descriptive Research Design 4. Human study : Inclusion Criteria: Patients presenting in Surgical OPD with Breast and related complaints Exclusion Criteria: Those who deny consent for participation. 5. Expected sample size : 823 Sample size calculation: Mentioned in methodology 6. Control groups : N/A 7. Probable duration of study: 365 days 8. Setting: Outpatient Department 9. Parameter/Variables to be applied/measured Independent Variables i. Socio-demographic characteristics such as age, gender, address. ii. Family History Dependent Variables: i. Clinical symptoms associated with breast disease ii. Type of breast disease (benign or malignant) Outcome measures: Primary (main outcome): All dependent variables (i) Rational for statistical methods to be employed : Retrospective Study Data will be entered in Microsoft Excel and converted it into SPSS for statistical analysis For descriptive studies, percentage, ratio, mean, SD, median will be calculated along with graphical and tabular presentations. For inferential statistics, bivariate analysis will be done using χ2 test and independent t test to find out the significant differences between dependent and independent variables at 95% confidence interval and p-value significant at <0.05. Multivariate logistic regression will be done to adjust for confounding. (ii) Ethical clearance : Ethical clearance will be obtained from Under Graduate Medical Research Protocol Review Board (UM-RPRB) of BPKIHS. (iii) Permission to use copyright questionnaire/Pro forma: Not applicable (j) Maintain the confidentiality of subject Confidentiality of the participants will be maintained. Whether available resources are adequate: Yes 1. Other resources needed: No 2. For Intervention trial: Not applicable A. Permission from Drug Controller of Nepal required/ Not required/Received/ Applied when_____ B. Safety measure C. Plan to withdraw


Clinical Trial Description

Pattern of clinical presentation of different breast disease in surgical opd at BPKIHS INTRODUCTION Breast is a dynamic gland that experiences physiological changes throughout a female's reproductive years. Adolescence, menarche, and menopause are notable periods during which significant changes occur in the breasts. Breast diseases are more prevalent in females and encompass a spectrum of benign, infectious, and malignant disorders. Benign breast diseases, constituting the majority of cases, encompass a range of lesions, including developmental abnormalities, inflammatory lesions, epithelial, and stromal proliferations, as well as various neoplasms. Benign breast disease is the primary cause of breast problems, with up to 30% of women experiencing a benign breast disorder that requires treatment at some point in their lives. The most common symptoms associated with these disorders are pain, lumpiness, or the presence of a lump. Breast cancer is most commonly observed in the Western world and is extremely rare before the age of 20 years. It is also rare in males. Breast cancer occurs more frequently in women with a family history of the disease. The typical presentation of breast cancer involves the presence of a hard lump, which may be associated with indrawing of the nipple or overlying skin. A study conducted in Nepal revealed that benign breast conditions accounted for 61.7% of cases, while malignancy accounted for 15.3%. Pain is one of the most common breast symptoms experienced by women. Breast pain is typically classified as cyclical mastalgia, noncyclical mastalgia, or extra mammary (non-breast) pain. Cyclic mastalgia is breast pain that follows a clear relationship to the menstrual cycle. Noncyclic mastalgia may be constant or intermittent and is not linked to the menstrual cycle; it often occurs after menopause. Extramammary pain arises from the chest wall or other sources but is interpreted as originating within the breast. The risk of cancer in a woman presenting with breast pain as her only symptom is extremely low. Breast lump/mass is also one of the most common breast symptoms. The discovery of a breast mass, whether self-detected or identified by a clinician, is a common and often distressing occurrence for many women. Although most detected breast masses are benign, it is essential for every woman presenting with a breast mass to undergo evaluation to rule out or diagnose cancer. Nipple discharge ranks as the third most common breast complaint, following breast pain and breast mass. It is usually a benign condition and can present in several forms, including milky, multicolored and sticky, purulent, clear and watery, yellow or serous, pink or serosanguinous, and bloody or sanguinous. The characteristics of the nipple discharge aid in the early diagnosis and management of breast disease. The most common cause of pathologic nipple discharge is a benign papilloma, followed by ductal ectasia, while carcinoma is the least likely cause. Breast diseases represent a significant health concern worldwide, including Nepal. Despite this, there have been relatively few studies conducted in Nepal to investigate the spectrum of breast diseases, and the available studies have been limited by small sample sizes. The current study aims to address this knowledge gap by examining the demographic profile of breast-related diseases and the rate of malignancy in our specific setting. The findings of this study can provide valuable information for healthcare providers in Nepal to improve early detection and management of breast diseases. Furthermore, it can serve as a foundation for future research to better understand the burden and nature of breast diseases in our population. This study's contribution to the global knowledge of breast diseases is particularly valuable, especially in countries with limited resources and healthcare infrastructure. Ultimately, the study seeks to enhance health outcomes and improve the quality of life for individuals affected by breast diseases in Nepal. In a study conducted in Olabisi Onabanjo University Teaching Hospital in Nigeria, breast lump was the commonest clinical feature of breast disease. Over 60% of these were benign. Breast pain was a statistically significant presentation in patients with malignant breast disease. In a study carried out at Chaudhry Rehmat Ali Memorial Trust Teaching Hospital Township Lahore, the commonest presentation was lump breast alone and it accounted for 50 patients of 142(35%). The other common symptom was lumpiness (19%) and pain in breast (14%). In a prospective study conducted in HBS Hospital Islamabad, which included total of 225 female patients, frequency of the disorders was as follows. Fibroadenoma breast presenting as lump breast was found in n=69(30.6%) followed by cyclical mastalgia(n=62 (27.5%), breast abscess n=27(12%), duct ectasia n=18(8%), carcinoma breast n=13(5.7%), sebaceous cyst breast n=9(4%), mastitis n=8(3%), cracked nipples n=8(3%), noncyclical mastalgia n=4(1.7%), galactorrhea n=3(0.8%), breast budding n=1(0.4%), phyllodes tumor n=1(0.4%), blood stained nipple discharge n=1(0.4%) and nipple eczema n=1(0.4%). In a three years study done in Maheshwara Medical College and Hospital in India 117 patients (110 Female and 7 Male) were studied. The maximum number of patients presented clinically with a lump in the breast (31.81%) and the second symptom was a pain in the breast (27.37%). The common breast diseases were benign and malignant neoplasms. In the benign conditions, most common was fibroadenoma (69 patients 62.72%) in young females. In older age >40 years, the breast cancer was common. All the seven male patients with breast enlargement clinically, diagnosed as gynecomastia and histopathologically confirmed. A prospective descriptive study conducted between January 2015 and May 2015 at Manipal Teaching Hospital, a tertiary level hospital situated in western region of Nepal where 160 patients presenting with benign breast diseases were studied. Majority were female (96%). The commonest presentation of benign breast diseases was pain (45%), followed by lump (26%). Fibroadenoma accounted for 46%. This study showed that among the benign breast diseases in females there were preponderance of mastalgia and fibroadenoma followed by fibrocystic diseases. METHODS The research utilized a Descriptive Research Design to investigate various study variables. The study focused on socio-demographic characteristics such as age, sex, and address, as well as breast symptoms like pain, lump, discharge, nipple retraction, and sub-areolar fistula. These factors served as outcome variables in the study. The research was conducted at B.P. Koirala Institute of Health Sciences (BPKIHS), and the study population consisted of patients who presented with breast and related complaints in the Surgical OPD. The sampling method included all patients who attended the surgical OPD with breast-related complaints, and data was collected using a semi-structured questionnaire through interviews. The sample size was justified based on literature review and prevalence study calculations. Inclusion criteria were patients who presented in the Surgical OPD with relevant complaints, while those who denied consent were excluded. The data collection involved a validated proforma with sections on sociodemographic profiles and contextual information related to presenting symptoms and family history. Consent was obtained, and English or Nepali questionnaires were used based on participant preference. Data entry was done in Microsoft Excel and the investigators used SPSS v11.5 for statistical analysis. We used descriptive and inferential statistical methods for data analysis. Descriptive statistics were presented in percentage, ratio, mean, SD and median along with presentation in graphical form. Categorical variables were analyzed with the χ2 test or with Fisher's exact test if at least one cell had an expected count < 5. P value <0.05 was considered to be significant. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06026176
Study type Observational
Source B.P. Koirala Institute of Health Sciences
Contact
Status Completed
Phase
Start date August 1, 2022
Completion date August 1, 2023

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05558917 - Comparison Between PECS BLOCK 2 vs ESP BLOCK in Ocnologic Breast Surgery N/A
Active, not recruiting NCT03664778 - Abbreviated Breast MRI After Cancer Treatment
Recruiting NCT03144622 - 18F-FSPG PET/CT Imaging in Patients With Cancers
Completed NCT05452499 - Pain Neuroscience Education and Therapeutic Exercise as a Treatment for Breast Cancer Survivors Living With Sequelae N/A
Active, not recruiting NCT04568902 - Study of H3B-6545 in Japanese Women With Estrogen Receptor (ER)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer Phase 1
Completed NCT02860585 - Evaluation of Survival in Patients With Metastatic Breast Cancer Receiving High-dose Chemotherapy With Autologous Haematopoietic Stem Cell Transplantation N/A
Completed NCT04059809 - Photobiomodulation for Breast Cancer Radiodermatitis Phase 2/Phase 3
Recruiting NCT04557449 - Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors Phase 1/Phase 2
Completed NCT03698942 - Delphinus SoftVue™ ROC Reader Study
Completed NCT00092950 - Exercise in Women at Risk for Breast Cancer Phase 2
Withdrawn NCT04123704 - Sitravatinib in Metastatic Breast Cancer Phase 2
Not yet recruiting NCT02151071 - The Breast Surgery EnLight and LightPath Imaging System Study Phase 1/Phase 2
Recruiting NCT02934360 - TR(ACE) Assay Clinical Specimen Study N/A
Active, not recruiting NCT02950064 - A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations Phase 1
Not yet recruiting NCT02876848 - A Novel E-Health Approach in Optimizing Treatment for Seniors (OPTIMUM Study) N/A
Completed NCT02931552 - Nuevo Amanecer II: Translating a Stress Management Program for Latinas N/A
Recruiting NCT02547545 - Breast Cancer Chemotherapy Risk Prediction Mathematical Model N/A
Completed NCT02652975 - Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium N/A
Completed NCT02303366 - Pilot Study of Stereotactic Ablation for Oligometastatic Breast Neoplasia in Combination With the Anti-PD-1 Antibody MK-3475 Phase 1
Completed NCT02518477 - Preventive Intervention Against Lymphedema After Breast Cancer Surgery N/A